UCB Unit Gets Form 483 for Deviation Investigation Shortfalls

Drug GMP Report
A pileup of complaints about ineffective drugs produced at Kremers Urban Pharmaceuticals’ Indiana plant appear to be linked to insufficient inquiries into drug defects, a Form 483 states.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $135.00